Cargando…

Fibrosis in Atrial Fibrillation – Role of Reactive Species and MPO

Atrial fibrosis with enhanced turnover and deposition of matrix proteins leads to inhomogeneous atrial electrical conduction and gives rise to electrical reentry circuits resulting in atrial fibrillation. The multifactorial pathogenesis of atrial fibrosis involves resident cardiac cells as well as i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friedrichs, Kai, Baldus, Stephan, Klinke, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379725/ https://www.ncbi.nlm.nih.gov/pubmed/22723783 http://dx.doi.org/10.3389/fphys.2012.00214

Ejemplares similares

Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation
por: Sovari, Ali A., et al.
Publicado: (2012)

Induction of Atrial Fibrillation by Neutrophils Critically Depends on CD11b/CD18 Integrins
por: Friedrichs, Kai, et al.
Publicado: (2014)

Levosimendan displays anti-inflammatory effects and decreases MPO bioavailability in patients with severe heart failure
por: Adam, Matti, et al.
Publicado: (2015)

Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins
por: Qiu, Huiliang, et al.
Publicado: (2018)

Wavelength and Fibrosis Affect Phase Singularity Locations During Atrial Fibrillation
por: Saha, Mirabeau, et al.
Publicado: (2018)

Role of Inflammation in the Pathogenesis of Atrial Fibrillation
por: Ihara, Kensuke, et al.
Publicado: (2022)

The Enzymatic and Non-Enzymatic Function of Myeloperoxidase (MPO) in Inflammatory Communication
por: Kargapolova, Yulia, et al.
Publicado: (2021)

Image-Based Computational Evaluation of the Effects of Atrial Wall Thickness and Fibrosis on Re-entrant Drivers for Atrial Fibrillation
por: Roy, Aditi, et al.
Publicado: (2018)

Elevated β1-Adrenergic Receptor Autoantibody Levels Increase Atrial Fibrillation Susceptibility by Promoting Atrial Fibrosis
por: Shang, Luxiang, et al.
Publicado: (2020)

Presence of Left Atrial Fibrosis May Contribute to Aberrant Hemodynamics and Increased Risk of Stroke in Atrial Fibrillation Patients
por: Paliwal, Nikhil, et al.
Publicado: (2021)

Epicardial Fibrosis Explains Increased Endo–Epicardial Dissociation and Epicardial Breakthroughs in Human Atrial Fibrillation
por: Gharaviri, Ali, et al.
Publicado: (2020)

The Critical Roles of Proteostasis and Endoplasmic Reticulum Stress in Atrial Fibrillation
por: Sirish, Padmini, et al.
Publicado: (2022)

Slow Conduction in the Border Zones of Patchy Fibrosis Stabilizes the Drivers for Atrial Fibrillation: Insights from Multi-Scale Human Atrial Modeling
por: Morgan, Ross, et al.
Publicado: (2016)

Atrial fibrillation and microRNAs
por: Santulli, Gaetano, et al.
Publicado: (2014)

Cerebrovascular Dysfunction in Atrial Fibrillation
por: Junejo, Rehan T., et al.
Publicado: (2020)

Immune remodeling and atrial fibrillation
por: Yao, Yajun, et al.
Publicado: (2022)

Acetylcholine Delays Atrial Activation to Facilitate Atrial Fibrillation
por: Bayer, Jason D., et al.
Publicado: (2019)

Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
por: Lv, Wenkui, et al.
Publicado: (2020)

Synaptic Plasticity in Cardiac Innervation and Its Potential Role in Atrial Fibrillation
por: Ashton, Jesse L., et al.
Publicado: (2018)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

SNP rs2243828 in MPO associated with myeloperoxidase level and atrial fibrillation risk in Chinese Han population
por: Wang, Pengyun, et al.
Publicado: (2020)

Atrial Fibrillation Mechanisms and Implications for Catheter Ablation
por: Cheniti, Ghassen, et al.
Publicado: (2018)

Nitric Oxide Synthases and Atrial Fibrillation
por: Bonilla, Ingrid M., et al.
Publicado: (2012)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Arrhythmogenic Substrates for Atrial Fibrillation in Obesity
por: Lubbers, Ellen R., et al.
Publicado: (2018)

The Role of CaMKII Overexpression and Oxidation in Atrial Fibrillation—A Simulation Study
por: Wang, Wei, et al.
Publicado: (2020)

Targeting Myeloperoxidase (MPO) Mediated Oxidative Stress and Inflammation for Reducing Brain Ischemia Injury: Potential Application of Natural Compounds
por: Chen, Shuang, et al.
Publicado: (2020)

Proteomic Analysis of Atrial Appendages Revealed the Pathophysiological Changes of Atrial Fibrillation
por: Liu, Ban, et al.
Publicado: (2020)

Inhibition of Adenosine Pathway Alters Atrial Electrophysiology and Prevents Atrial Fibrillation
por: Soattin, Luca, et al.
Publicado: (2020)

Linking Electrical Drivers With Atrial Cardiomyopathy for the Targeted Treatment of Atrial Fibrillation
por: Ho, Gordon, et al.
Publicado: (2020)

Premature atrial contractions: A predictor of atrial fibrillation and a relevant marker of atrial cardiomyopathy
por: Guichard, Jean-Baptiste, et al.
Publicado: (2022)

Xanthine Oxidase and Uric Acid in Atrial Fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2012)

Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure
por: Denham, Nathan C., et al.
Publicado: (2018)

Colchicine in atrial fibrillation: are old trees in bloom?
por: Zhan, Yujia, et al.
Publicado: (2023)

Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats
por: Mulla, Wesam, et al.
Publicado: (2019)

Higher Incidence of Atrial Fibrillation in Left Ventricular-to-Right Atrial Shunt Patients
por: Chou, Hongda, et al.
Publicado: (2020)

Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation
por: Jansen, Hailey J., et al.
Publicado: (2022)

Left Atrial Enhancement Correlates With Myocardial Conduction Velocity in Patients With Persistent Atrial Fibrillation
por: Ali, Rheeda L., et al.
Publicado: (2020)

Localized Pulmonary Vein Scar Promotes Atrial Fibrillation in High Left Atrial Pressure
por: Gottlieb, Lisa A., et al.
Publicado: (2021)

Inhibition of EPAC1 signaling pathway alters atrial electrophysiology and prevents atrial fibrillation
por: Guillot, Bastien, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ckpnmjq5faj9a41klouoiglsn